Under construction – not a live service
Sign in
Taking people in EthiopiaNo phase

Peer-led education for adults being treated for drug-susceptible lung tuberculosis in Ethiopia

Tests education led by peers in adults treated for lung tuberculosis.

Plain-language title generated from the registry record
Registry title: Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia

Key facts

Where
Jinka, EthiopiaSee the site

Where in Ethiopia

  • Jinka UniversityJinka, EthiopiaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Bahirdar University
Trial code
NCT07387601
Record updated
6 July 2026
Original description
The study might come up with valuable findings to address poor treatment outcome, poor quality of life, disability score and depressive symptoms. The findings may also be decreased health professional workload. The findings would be supportive evidences for policy makers, program managers, to clinician as well as the patients themselves and for other researchers. The study may help to promote and maintain good treatment outcome for the patients in the study area as well as the country. The findings will also be used for teaching \& learning purposes in educational \& training programs.Read full original descriptionShow less

Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia: A Protocol for a Cluster- Randomized Controlled Trial Study

The study might come up with valuable findings to address poor treatment outcome, poor quality of life, disability score and depressive symptoms. The findings may also be decreased health professional workload. The findings would be supportive evidences for policy makers, program managers, to clinician as well as the patients themselves and for other researchers. The study may help to promote and maintain good treatment outcome for the patients in the study area as well as the country. The findings will also be used for teaching \& learning purposes in educational \& training programs.

Inclusion: Adults with new drug-susceptible pulmonary TB who will be diagnosed in bacteriological diagnostic methods; not participating in similar study,; mentally capable to provide consent,; physically capable of following the intervention.

Exclusion: Tuberculosis patients with a known plan to be transferred out of the study sites; Seriously ill patients at the time of screening or enrollment.

ClinicalTrials.gov NCT07387601